Barbara A. Goff, MD
Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.
Physician
Seattle Cancer Care Alliance
Seattle Cancer Care Alliance
Professor, Division of Gynecologic Oncology
University of Washington School of Medicine
University of Washington School of Medicine
Chair, Obstetrics and Gynecology
UW Medicine
UW Medicine
Affiliate Investigator
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Clinical expertise
Gynecologic oncology
Gynecologic oncology
Located at
“
I believe in a comprehensive and compassionate multidisciplinary approach to treatment of gynecological malignancies.
”—
Dr. Goff
Clinical expertise
Gynecologic Oncology
Gynecologic Oncology
Medical Degree
University of Pennsylvania School of Medicine
University of Pennsylvania School of Medicine
Residency
Brigham and Women's Hospital, Obstetrics & Gynecology
Brigham and Women's Hospital, Obstetrics & Gynecology
Fellowship
Massachusetts General Hospital, Gynecology & Oncology
Massachusetts General Hospital, Gynecology & Oncology
Board Certification
Gynecologic Oncology, 1996; Obstetrics & Gynecology, 1994, American Board of Obstetrics & Gynecology
Gynecologic Oncology, 1996; Obstetrics & Gynecology, 1994, American Board of Obstetrics & Gynecology
Languages
English
Your care team
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and
treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.
Clinical trials
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
A Phase I/Ib Study of NIZ985 in Combination With PDR001 in Adults With Metastatic Cancers
Study No:
NCT02452268
Phase:
Phase I
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Study No:
NCT02502266
Phase:
Phase II/III
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Study No:
NCT02601950
Phase:
Phase II
Publications
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
Two cases of extragonadal malignant transformation of endometriosis after TAH/BSO for benign indications.
Reply.